Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning Target Sites for the DNA-Binding Protein PAX-6
Carulli, John P.
Oscient Pharmaceuticals Corporation, Waltham, MA, United States
Search grants from John Carulli
Search grants from Oscient Pharmaceuticals Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Administrative
Emerging Infectious Diseases
Professional Nurse Traineeship
Divergence of long intergenic noncoding RNAs in Drosophila pseudoobscura, Drosophila persimilis, and their hybrids
Mathematical Foundations of Databases
Recently added grants:
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
Sushi domain proteins as synapse protective factors in brain development and aging
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
Dissecting the Link Between Ureagenesis and Hepatic Glycogen Metabolism
Personalized protein-protein interactomes and precision medicine in pulmonary arterial hypertension
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033803-02
Application #
2037906
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Program Officer
Small, Judy A
Project Start
1995-02-13
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Oscient Pharmaceuticals Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Related projects
NIH 1997
R44 NS
Cloning Target Sites for the DNA-Binding Protein PAX-6
Artinger, Michael A. / Oscient Pharmaceuticals Corporation
NIH 1996
R44 NS
Cloning Target Sites for the DNA-Binding Protein PAX-6
Carulli, John P. / Oscient Pharmaceuticals Corporation
Comments
Be the first to comment on John Carulli's grant